Incidence, Implications, and Predictors of Stent Thrombosis in Acute Myocardial Infarction

Area of Science:

• Cardiology
• Interventional Cardiology
• Clinical Research

Background:

• Stent thrombosis (ST) is a serious complication following percutaneous coronary intervention (PCI).
• Data on ST incidence, outcomes, and predictors in acute myocardial infarction (AMI) patients are limited.
• Understanding ST in AMI is crucial for improving patient management and outcomes.

Purpose of the Study:

• To determine the incidence, implications, and predictors of ST in patients with AMI undergoing PCI.
• To analyze the long-term occurrence of ST, including early, late, and very late phases.
• To identify factors associated with increased risk of ST in this high-risk population.

Main Methods:

• Prospective enrollment of AMI patients undergoing PCI in the CardiOvascular Risk and idEntificAtion of potential high-risk population in AMI registry (2004-2009).
• Analysis of definite or probable ST cases based on Academic Research Consortium definitions.
• Median follow-up of 41.9 months to assess ST occurrence and patient mortality.

Main Results:

• Definite or probable ST occurred in 3.7% of patients (136/3676).
• ST incidence included early (1.0%), late (0.9%), and very late (2.0%), with annual very late ST rates of 0.5%-0.6%.
• All-cause mortality was significantly higher in patients with ST (29%) compared to those without (17%).
• Independent predictors of ST were no-reflow phenomenon, decreased left ventricular ejection fraction, anemia, and mean stent diameter <3.0 mm.

Conclusions:

• Stent thrombosis is a significant and persistent risk in AMI patients post-PCI, extending beyond one year.
• Patients experiencing ST face substantially higher mortality rates.
• No-reflow, reduced ejection fraction, anemia, and smaller stent diameter are critical independent predictors of ST in AMI patients.